VERACYTE, INC. Uncategorized Contracts & Agreements

15 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Advisor Agreement, effective September 4, 2023, by and between Tina S. Nova and the Registrant
VERACYTE, INC.
Biotechnology
2023
Offer Letter, dated as of January 9, 2023, between Annie McGuire and the Registrant
VERACYTE, INC.
Biotechnology
2023
Offer Letter, dated as of February 7, 2022, between Annie McGuire and the Registrant
VERACYTE, INC.
Biotechnology
2022
Offer Letter, dated as of February 2, 2021, between Tina S. Nova and the Registrant
VERACYTE, INC.
Biotechnology
DE
2022
Amended and Restated Offer Letter, dated August 15, 2021, between the Registrant and Rebecca Chambers
VERACYTE, INC.
Biotechnology
2021
Offer Letter dated as of
VERACYTE, INC.
Biotechnology
2021
Description of Securities Registered under Section 12 of the Securities Exchange Act of 1934, as amended
VERACYTE, INC.
Biotechnology
2021
Offer Letter dated as of August 9, 2011 with John Hanna
VERACYTE, INC.
Biotechnology
2020
Offer Letter dated as of March 5, 2008 with Giulia Kennedy
VERACYTE, INC.
Biotechnology
2020
Description of Securities Registered under Section 12 of the Securities Exchange Act of 1934, as amended
VERACYTE, INC.
Biotechnology
2020
Agreement dated as of October 16, 2017, between Thyroid Cytopathology Partners, P.A. and the Registrant, as amended
VERACYTE, INC.
Biotechnology
TX
2019
Offer Letter dated as of November 17, 2016 with Keith Kennedy
VERACYTE, INC.
Biotechnology
2018
EX-U.S. CO-PROMOTION AGREEMENT
VERACYTE, INC.
Biotechnology
NY
2015
AMENDED AND RESTATED U.S. CO-PROMOTION AGREEMENT
VERACYTE, INC.
Biotechnology
NY
2014
Letter of Agreement for Proposed Second Amendment to Co-Promotion Agreement
VERACYTE, INC.
Biotechnology
2014